financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Hold Opinion On Adss Of Vipshop Holdings Limited
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Hold Opinion On Adss Of Vipshop Holdings Limited
Sep 11, 2025 9:54 PM

12:40 AM EDT, 09/12/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We maintain our Hold opinion and raise our target price to USD20 from USD16 (based on a 9.4x 2025 P/E vs. its 6.9x three-year mean), expecting gradual improvement from government stimulus measures and the company's focus on expanding Super VIP membership to drive higher ARPU and profitability. Vipshop Holdings ( VIPS ) reported weak H1 2025 results, with revenue declining 4.4% Y/Y to CNY52.07B, missing expectations as Q2 revenue fell 4% and Q1 dropped 5%, reflecting challenging business conditions within management's guidance for a flat to 5% decline. Active customers decreased 1.7% and total orders fell 2.4% to 193.0M in Q2, though Super VIP customers grew 15% Y/Y, demonstrating strength in the company's high-value customer segment. We believe VIPS' flash sales model and discounted branded offerings position it well for China's consumption upgrade, especially among its middle-class population, though intense competition from live-streaming e-commerce and limited global exposure constrain near-term catalysts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Cvs Health Corporation
Research Alert: CFRA Keeps Hold Opinion On Shares Of Cvs Health Corporation
Nov 11, 2025
11:45 AM EST, 11/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target price by $17, to $85, valuing CVS shares at 10.6x our newly initiated 2027 EPS estimate of $8.05 and at 11.9x our 2026 EPS estimate...
Research Alert: CFRA Lowers Opinion On Shares Of Six Flags Entertainment Corp To Hold From Buy
Research Alert: CFRA Lowers Opinion On Shares Of Six Flags Entertainment Corp To Hold From Buy
Nov 11, 2025
11:25 AM EST, 11/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month price target by $9 to $18, based on an 8x EV/EBITDA multiple (unchanged) on our 2026 estimate, in line with FUN's near-term average forward multiple. We...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Canada Goose; Raises Price Target
Research Alert: CFRA Maintains Buy Opinion On Shares Of Canada Goose; Raises Price Target
Nov 11, 2025
11:55 AM EST, 11/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month price target by CAD4 to CAD20, based on 18x our FY 26 EPS estimate and in line with the company's three-year average forward P/E multiple. This...
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Cigna Group
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Cigna Group
Nov 11, 2025
01:10 PM EST, 11/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price of $310, valuing the shares at 9.1x our newly introduced 2027 EPS estimate of $33.90 and at 10x our 2026 EPS estimate of $30.85...
Copyright 2023-2026 - www.financetom.com All Rights Reserved